Major Growth Driving Factors:

The antimicrobial susceptibility testing (AST) market is expanding due to a number of causes, including the increased frequency of infectious diseases, the high level of antibiotic resistance, and the government's supportive efforts to reduce the burden of infectious diseases. Antibiotic resistance testing is becoming more common as a result of an increase in certain ailments, including bloodstream infections and pneumonia caused by K. pneumonia, P. aeruginosa, and E. coli, among others.

Future Revenue Growth Prospects:

The size of global antimicrobial susceptibility testing market in terms of revenue was estimated to be worth $3.6 billion in 2022 and is poised to reach $4.7 billion by 2027, growing at a CAGR of 5.5% from 2022 to 2027.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206359984

Market Estimation Methodology:

The revenue share analysis of the top competitors in the antimicrobial susceptibility testing market was used to determine the market size in this study. In order to achieve this, major market participants were identified, and their earnings from the medical aesthetics industry were calculated using a variety of insights obtained throughout the main and secondary research stages. Examining the annual and financial reports of the leading market participants was one aspect of secondary research. On the other hand, in-depth interviews with significant thought leaders, including directors, CEOs, and important marketing executives, were a part of the primary study.

To calculate the global market value, segmental revenues were calculated based on the revenue mapping of major solution/service providers. This process involved the following steps:

# Generating a list of major global players operating in the microcatheter market.
# Mapping annual revenues generated by major global players from the product segment (or nearest reported business unit/product category)
# Revenue mapping of major players to cover major share of the global market share, as of 2021
# Extrapolating the global value of the automated antimicrobial susceptibility testing market

Data Triangulation:

The antimicrobial susceptibility testing market was divided into segments and subsegments after the overall market size was determined using the previously described market size estimation process. Procedures for data triangulation and market breakdown were used to finish the entire market engineering process and determine precise statistics for each segment and subsegment. By examining numerous variables and trends from the supply and demand sides, data was triangulated.

Additionally, both top-down and bottom-up methods were used to validate the antimicrobial susceptibility testing market. The market was divided into segments and sub-segments once the overall market size was determined using the previously described market size estimation process. To finish the entire market engineering process and determine the precise statistics for each sector and subsegment, techniques such as data triangulation and market breakdown were used.

Opportunity: Growth opportunities in emerging market

Emerging countries such as APAC, India, China and Japan present significant opportunities for players operating in the Antimicrobial susceptibility testing market. The demand for Antimicrobial susceptibility testing market in these countries is increasing owing to rapid growth in medical tourism, the growing adult (aged 20 and above) population, increasing drug abuse. These countries are also home to a strong and qualified workforce and have a great knowledge of advance technologies. Furthermore, these countries have lenient policies for imports/exports and are underpenetrated in most aspects, which could help companies in brand development. Increasing developing technicians and the keen to know about new technologies is helping the regions to grow and update their technologies.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=206359984

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]